Respiratory Viruses and Mycoplasma Pneumoniae Surveillance Among Hospitalized Children with Acute Respiratory Infections - Wuhan City, Hubei Province, China, September-November 2023

China CDC Wkly. 2024 Feb 23;6(8):139-142. doi: 10.46234/ccdcw2024.027.

Abstract

What is already known about this topic?: Acute respiratory infections (ARIs) are a significant contributor to illness and death in children. There has been a notable rise in the occurrence of ARIs and the associated pathogens in China, which has garnered worldwide attention.

What is added by this report?: This study conducted a retrospective analysis of the clinical characteristics of children with ARIs in Wuhan City from September to November 2023. The study evaluated the epidemiological patterns of common respiratory viruses and Mycoplasma pneumoniae (MP), revealing a continued prevalence of MP and a growing trend of influenza. Our findings emphasize that the circulation of respiratory viruses and MP has not returned to pre-pandemic levels, underscoring the importance of enhancing surveillance for respiratory pathogens.

What are the implications for public health practice?: The epidemiology of ARIs and the pathogens involved need to be emphasized. This highlights the importance of developing policies to protect children from respiratory pathogens such as MP, influenza, and respiratory syncytial virus.

Keywords: COVID-19; Epidemiology; Mycoplasma pneumoniae; Respiratory viruses.

Grants and funding

Supported by the National Key Research and Development Program of China (2018YFC1603803), the National Natural Science Foundation of China (31970548), the Knowledge Innovation Program of Wuhan Basic Research (2022020801010569), the Health Commission of Hubei Province (WJ 2021M262), and the Natural Science Fund of Hubei Province (2021CFA012, 2023AFB221)